Olena Morozova
机构: Genome Sciences Centre, BC Cancer Agency
每年引用次数
引用次数
引用: 5,679
H-指数: 18
I10-指数 : 18
出版物: 30
Genomic studies of the normal and malignant neural crest
Olena Morozova
University of British Columbia
2012
SKPs Derive from Hair Follicle Precursors and Exhibit Properties of Adult Dermal Stem Cells
Freda D. Miller , Jeffrey Biernaskie , Maryline Paris , Olena Morozova
Cell Stem Cell 5 ( 6) 610 -623
382
2009
DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma.
Michael D. Blough , Mohammad Al-Najjar , Charles Chesnelong , Carmen E. Binding
Annals of Neurology 71 ( 6) 845 -849
18
2012
Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance.
Michael D O’Connor , Elizabeth Wederell , Gordon Robertson , Allen Delaney
Experimental Hematology 39 ( 8) 866 -879
25
2011
LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer
Tammy L Romanuik , Gang Wang , Olena Morozova , Allen Delaney
BMC Medical Genomics 3 ( 1) 43 -43
120
2010
Selective targeting of neuroblastoma tumour‐initiating cells by compounds identified in stem cell‐based small molecule screens
Kristen M Smith , Alessandro Datti , Mayumi Fujitani , Natalie Grinshtein
Embo Molecular Medicine 2 ( 9) 371 -384
60
2010
Applications of New Sequencing Technologies for Transcriptome Analysis
Olena Morozova , Martin Hirst , Marco A. Marra
Annual Review of Genomics and Human Genetics 10 ( 1) 135 -151
637
2009
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.
Stephen Yip , Yaron S Butterfield , Olena Morozova , Suganthi Chittaranjan
The Journal of Pathology 226 ( 1) 7 -16
315
2012
System-Level Analysis of Neuroblastoma Tumor–Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma
Milijana Vojvodic , Natalie Grinshtein , Loen M. Hansford , Kim M. Blakely
Clinical Cancer Research 16 ( 18) 4572 -4582
37
2010
A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines.
Miliana Vojvodic , Loen Hansford , Olena Morozova , Kim Blakely
Current Drug Discovery Technologies 10 ( 4) 283 -304
3
2013
A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer
Sara M. Nolte , Chitra Venugopal , Nicole McFarlane , Olena Morozova
Journal of the National Cancer Institute 105 ( 8) 551 -562
44
2013
Applications of next-generation sequencing technologies in functional genomics.
Olena Morozova , Marco A. Marra
Genomics 92 ( 5) 255 -264
1,568
2008
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth.
Bikul Das , Roula Antoon , Rika Tsuchida , Shamim Lotfi
Neoplasia 10 ( 10) 1105 -1119
103
2008
Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression
Alireza Baradaran-Heravi , Kyoung Sang Cho , Bas Tolhuis , Mrinmoy Sanyal
Human Molecular Genetics 21 ( 11) 2572 -2587
45
2012
Convergent Genesis of an Adult Neural Crest-Like Dermal Stem Cell from Distinct Developmental Origins
Hiroyuki Jinno , Olena Morozova , Karen L. Jones , Jeffrey A. Biernaskie
STEM CELLS 28 ( 11) 2027 -2040
94
2010
A Seriation Approach for Visualization-Driven Discovery of Co-Expression Patterns in Serial Analysis of Gene Expression (SAGE) Data
Olena Morozova , Vyacheslav Morozov , Brad G. Hoffman , Cheryl D. Helgason
PLoS ONE 3 ( 9) e3205
1
2008
The genetic landscape of high-risk neuroblastoma
Trevor J Pugh , Olena Morozova , Edward F Attiyeh , Shahab Asgharzadeh
Nature Genetics 45 ( 3) 279 -284
660
2013
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Kathryn R Taylor , Alan Mackay , Nathalène Truffaux , Yaron S Butterfield
Nature Genetics 46 ( 5) 457 -461
315
2014
Rare DNA variants are enriched at the BARD1 locus and likely influence neuroblastoma susceptibility.
Andrew C Wood , Trevor J Pugh , Olena Morozova , Jan Koster
Cancer Research 73 ( 8_Supplement) 3804 -3804
2013
GERMLINE VARIATIONS ARE ASSOCIATED WITH SUSCEPTIBILITY TO HIGH-RISK NEUROBLASTOMA AND IDENTIFY PATHWAYS WITH GAIN OF FUNCTION
Andrew Wood , Kristopher Bosse , Kai Wang , Sharon Diskin
PEDIATRIC BLOOD & CANCER 57 ( 5) 724 -724
2011